29.01.2013 • News

Weylchem International Confirms Business Development Strategy

Weylchem International announces sales organization changes to capitalize on greater market presence in the field of advanced intermediates and reagents (AIR).

Weylchem Group, a global leader in fine chemical products and solutions, announced a transformation in its go-to-market sales strategy with a new geographically-focused business development structure and team of Sales & Marketing managers. This realignment is consistent with the Group's strategy to build upon its expanded customer base worldwide.

"As a result of our rapid growth, this is an optimal time to realign our sales strategy and organizational structure to build scale and new opportunities," said Dr. Tomas Hainich, President of the WeylChem Group. "We now have a well-organized International sales team enabling us to better leverage our strong pipeline of new business opportunities."

The new structure includes the appointment of the following Sales & Marketing Managers with global responsibility of product management:
• Karl Reinhard, - Oxidation Products.
• Dr. Ralf Oeschey, - Side Chain Chlorination.
• Jacques Sturm, - Potassium and Chlorine Derivatives.
• Lionel Wassner, - Brominated Derivatives
• Doug Welter, Sales & Marketing Director for Grignards Reagents
• Dario Monti, - Fluorinated Derivatives.

The AIR Sales & Marketing team will report to Marie-Laure Vallée, Global Business Director of Weylchem Advanced Intermediates & Reagents. Mrs. Vallée will join the WCI team of AIR&PP, led by Brian McGlynn, who was also recently nominated as Managing Director of Weylchem International.

Company

Logo:

WeylChem International GmbH

Alt-Fechenheim 34
60386 Frankfurt
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read